The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes1
Abstract
In adults, endogenous hyperinsulinemic hypoglycemia is almost invariably due to insulinoma. In these patients with insulinoma, neuroglycopenic episodes exclusively after meal ingestion and negative 72-h fasts are extraordinarily rare. We describe five adults with neuroglycopenic episodes from hyperinsulinemic hypoglycemia within 4 h of meal ingestion and negative 72-h fasts. Each had negative transabdominal ultrasonography, spiral computed tomographic scanning, and celiac axis angiography of the pancreas. However, all showed positive selective arterial calcium stimulation tests indicative of pancreatic beta-cell hyperfunction. At pancreatic exploration, no insulinoma was detected by intraoperative ultrasonography and complete mobilization and palpation of the pancreas. Moreover, the resected pancreata showed islet hypertrophy and nesidioblastosis, but no insulinoma. No definite disease-causing mutation was detected in Kir6.2 and SUR1 genes, which encode the subunits of the pancreatic ATP-sensitive potassium channel responsible for glucose-induced insulin secretion. Four patients who underwent gradient-guided partial pancreatectomy have been free of hypoglycemic symptoms for up to 3 yr follow-up; the other, who underwent a limited distal pancreatectomy, has had brief recurrence of symptoms. The unique clinical features and responses to dynamic testing in these adults with hyperinsulinemic hypoglycemia in the absence of insulinoma may constitute a new syndrome of postprandial hypoglycemia from diffuse beta-cell hyperfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thomas, P. M., Cote, G. J., Wohllk, N., Haddad, B., Mathew, P. M., Rabl, W., Aguilar-Bryan, L., Gagel, R. F., & Bryan, J. (1995) · Science · doi:10.1126/science.7716548 · Cited by 806
Automated kinetic method for D-3-hydroxybutyrate in plasma or serum
McMurray, C. H., Blanchflower, W. J., & Rice, D. A. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.3.421 · Cited by 188
A glucose-responsive insulinoma.
Power, L. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03150180023004 · Cited by 24
Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.
Rayman, G., Santo, M., Salomon, F., Almog, S., Paradinas, F. J., Pinkhas, J., Reynolds, K. W., & Wise, P. H. (1984) · Journal of Clinical Pathology · doi:10.1136/jcp.37.6.651 · Cited by 21
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationFrancis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Self-citationHyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Self-citationThe diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377
“A similar syndrome occurring in adults without GB, known as noninsulinoma pancreatogenous hyperinsulinemic hypoglycemia, itself is rare (20, 21).”
BackgroundPatti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1933-x · Cited by 365
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
de Herder, W. W., Niederle, B., Scoazec, J.-Y., Pauwels, S., Klöppel, G., Falconi, M., Kwekkeboom, D. J., Öberg, K., Eriksson, B., Wiedenmann, B., et al. (2006) · Neuroendocrinology · doi:10.1159/000098010 · Cited by 295
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
DUNNE, M. J., COSGROVE, K. E., SHEPHERD, R. M., AYNSLEY-GREEN, A., & LINDLEY, K. J. (2004) · Physiological Reviews · doi:10.1152/physrev.00022.2003 · Cited by 294
Forty-Eight-Hour Fast: The Diagnostic Test for Insulinoma
Hirshberg, B., Livi, A., Bartlett, D. L., Libutti, S. K., Alexander, H. R., Doppman, J. L., Skarulis, M. C., & Gorden, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6807 · Cited by 256
Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances
Ito, T., Igarashi, H., & Jensen, R. T. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.12.003 · Cited by 256
Meier, J. J., Butler, A. E., Galasso, R., & Butler, P. C. (2006) · Diabetes Care · doi:10.2337/dc06-0392 · Cited by 249
Anlauf, M., Wieben, D., Perren, A., Sipos, B., Komminoth, P., Raffel, A., Kruse, M. L., Fottner, C., Knoefel, W. T., Mönig, H., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000151617.14598.ae · Cited by 167
“Among the various indicators of islet changes, b-cell hypertrophy characterized by enlarged and hyperchromatic b-cell nuclei was the most significant and diagnostic finding in patients with PHH.”
BackgroundResultInfluentialVezzosi, D., Bennet, A., Fauvel, J., & Caron, P. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0109 · Cited by 152
Cappellani, D., Macchia, E., Falorni, A., & Marchetti, P. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s219438 · Cited by 138
Clancy, T. E., Moore, F. D., & Zinner, M. J. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.04.008 · Cited by 133
Rosati, B., Marchetti, P., Crociani, O., Lecchi, M., Lupi, R., Arcangeli, A., Olivotto, M., & Wanke, E. (2000) · The FASEB Journal · doi:10.1096/fj.00-0077com · Cited by 133
Noninsulinoma pancreatogenous hypoglycemia syndrome: An update in 10 surgically treated patients
Thompson, G. B., Service, F. J., Andrews, J. C., Lloyd, R. V., Natt, N., van Heerden, J. A., & Grant, C. S. (2000) · Surgery · doi:10.1067/msy.2000.110243 · Cited by 121
Self-citationAdult diffuse nesidioblastosis: genetically or environmentally induced?
Klöppel, G., Anlauf, M., Raffel, A., Perren, A., & Knoefel, W. T. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.010 · Cited by 108
Rumilla, K. M., Erickson, L. A., Service, F. J., Vella, A., Thompson, G. B., Grant, C. S., & Lloyd, R. V. (2009) · Modern Pathology · doi:10.1038/modpathol.2008.169 · Cited by 85
Self-citationThompson, S. M., Vella, A., Thompson, G. B., Rumilla, K. M., Service, F. J., Grant, C. S., & Andrews, J. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2404 · Cited by 80
“Once factitious disease from inappropriate use of insulin or sulfonylurea has been excluded, the differential diagnosis devolves primarily to focal insulinoma or noninsulinoma pancreatogenous hypoglycemic syndrome (NIPHS) resulting from diffuse -cell hyperplasia or nesidioblastosis (1, 3, 4).”
BackgroundSelf-citationInsulin autoimmunity and hypoglycemia in seven white patients.
Basu, A., Service, F. J., Yu, L., Heser, D., Ferries, L. M., & Eisenbarth, G. (2005) · Endocrine Practice · doi:10.4158/ep.11.2.97 · Cited by 66
Self-citationVanderveen, K. A., Grant, C. S., Thompson, G. B., Farley, D. R., Richards, M. L., Vella, A., Vollrath, B., & Service, F. J. (2010) · Surgery · doi:10.1016/j.surg.2010.09.027 · Cited by 67
Self-citationHormonal Response to a Mixed-Meal Challenge After Reversal of Gastric Bypass for Hypoglycemia
Lee, C. J., Brown, T., Magnuson, T. H., Egan, J. M., Carlson, O., & Elahi, D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1151 · Cited by 65
Yamada, Y., Kitayama, K., Oyachi, M., Higuchi, S., Kawakita, R., Kanamori, Y., & Yorifuji, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13180 · Cited by 63
Nesidioblastosis: An Old Term and a New Understanding
Kaczirek, K., & Niederle, B. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7598-7 · Cited by 62
Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia
Mathavan, V. K., Arregui, M., Davis, C., Singh, K., Patel, A., & Meacham, J. (2010) · Surgical Endoscopy · doi:10.1007/s00464-010-1001-6 · Cited by 61
Alvarez, G. C., Faria, E. N., Beck, M., Girardon, D. T., & Machado, A. C. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9096-0 · Cited by 61
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism.
Kaczirek, K., Soleiman, A., Schindl, M., Passler, C., Scheuba, C., Prager, G., Kaserer, K., & Niederle, B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01158.x · Cited by 57
Post-bypass hypoglycaemia: A review of current findings
Ritz, P., & Hanaire, H. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.04.003 · Cited by 56
Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature
Jabri, A. L., & Bayard, C. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.06.012 · Cited by 56
The treatment of hyperinsulinemic hypoglycaemia in adults: an update
On behalf of NIKE Group, Davi′, M. V., Pia, A., Guarnotta, V., Pizza, G., Colao, A., & Faggiano, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0536-3 · Cited by 51
Starke, A., Saddig, C., Kirch, B., Tschahargane, C., & Goretzki, P. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0543-6 · Cited by 46
Successful Treatment of Persistent Hyperinsulinemic Hypoglycemia with Nifedipine in an Adult Patient
Guseva, N., Phillips, D., & Mordes, J. P. (2010) · Endocrine Practice · doi:10.4158/ep09110.crr · Cited by 35
“The available imaging and physiologic data suggest that this patient’s diagnosis is most likely noninsulinoma pancreatogenous hypoglycemia syndrome or organic persistent hyperinsulinemic hypoglycemia (13,17).”
MethodResultHyperinsulinemic hypoglycemia following gastric bypass surgery for obesity.
Goldfine, A. B., Mun, E., & Patti, M. E. (2006) · Current Opinion in Endocrinology and Diabetes · doi:10.1097/01.med.0000244222.91280.71 · Cited by 26
Noninsulinoma Pancreatogenous Hypoglycemia Syndrome: A Rare Case of Adult-onset Nesidioblastosis
TSUJINO, M., SUGIYAMA, T., NISHIDA, K., TAKADA, Y., TAKANISHI, K., ISHIZAWA, M., & HIRATA, Y. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.843 · Cited by 24
Dieterle, M. P., Husari, A., Prozmann, S. N., Wiethoff, H., Stenzinger, A., Röhrich, M., Pfeiffer, U., Kießling, W. R., Engel, H., Sourij, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061732 · Cited by 19
Nesidioblastosis with Glucagon-Reactive Islet Cell Hyperplasia: A Case Report
Martignoni, M. E., Kated, H., Stiegler, M., Büchler, M. W., Friess, H., Zimmermann, A., Schirp, U., & Nitzsche, E. U. (2003) · Pancreas · doi:10.1097/00006676-200305000-00016 · Cited by 17
Hypoglycemia due to an adult-onset nesidioblastosis, a diagnostic and management dilemma
Qintar, M., Sibai, F., & Taha, M. (2012) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.99164 · Cited by 17
“Histopathology descriptions of excised pancreatic tissue include islet cell hypertrophy with enlarged and hyperchromatic nuclei, increased periductular islets ,and β-cells budding off ductular epithelium.[12,13]”
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome.
Manning, P. J., Espiner, E. A., Yoon, K., Drury, P. L., Holdaway, I. M., & Bowers, A. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01033.x · Cited by 16
De Sousa, S. M. C., Haghighi, K. S., Qiu, M. R., Greenfield, J. R., & Chen, D. L. T. (2016) · Pancreas · doi:10.1097/mpa.0000000000000430 · Cited by 13
An unusual cause of hypoglycemia in a middle-aged female after bariatric surgery
Pathak, R., Karmacharya, P., Salman, A., & Alweis, R. (2014) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v4.23118 · Cited by 10
Hypoglycaemia in an adult male: A surprising finding in pursuit of insulinoma
Geraghty, M., Draman, M., Moran, D., Muldoon, C., Reynolds, J. V., & Cullen, M. J. (2008) · The Surgeon · doi:10.1016/s1479-666x(08)80097-2 · Cited by 6
Dieterle, M. P., Husari, A., Prozmann, S. N., Wiethoff, H., Stenzinger, A., Röhrich, M., Pfeiffer, U., Kießling, W. R., Engel, H., Sourij, H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061741 · Cited by 9
“described the common findings associated with nesidioblastosis in 1999, and defined the term NIPHS for the clinical syndrome [26].”
BackgroundMethodInfluential
Metadata
- Authors
- Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-05
- Volume
- 84
- Issue
- 5
- Pages
- 1582-1589
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2010735159
- Cited by
- 196
- References
- 4
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.